Updated May 2026 badgerskope.com Peptide literacy · Independent
WE READ THE STUDIES SO YOU DON'T HAVE TO

EVIDENCE HYPE

BadgerSkope is a free, independent reference that tells you which peptides are backed by real human studies — and which are mostly internet rumor. We read the studies so you don't have to.

What's a peptide? A short chain of amino acids. Some are FDA-approved drugs (like Ozempic). Some are research compounds sold grey-market online. Some are pure marketing. We sort them.

Reader-funded · no vendor money · no affiliate links

Open the library → How we grade
See how we grade ↓
This week's anchor file

BPC-157

One of the most-talked-about peptides on the internet. Sold as a tendon and gut healer. The animal evidence is real and consistent. The human evidence is two trials, neither finished.

Lab name: PL 14736. A short, 15-amino-acid peptide.
BEVIDENCE BSAFETY BACCESS

BPC-157 is the most-Googled peptide on the internet and has exactly two registered human trials. Both of those things are true at the same time.

See how we graded this →
Updated 18 Apr 2026 · re-reviewed when new data lands
FILE 01 — THE NOISE

THE INTERNET TELLS YOU
EVERYTHING WORKS.

Same compound, four different stories. Here's what each one usually leaves out.

PODCAST
“It's basically magic.”
What's missing: the “magic” is one rat study from 2014.
VENDOR
“Research-grade, 99% purity.”
What's missing: no independent lab report, no batch number, no manufacturer.
INFLUENCER
“I lost 30 lbs on it.”
What's missing: they were also dieting, training, and paid to post.
FORUM
“Stack it for synergy.”
What's missing: nobody has actually measured what the combination does in the body.
FILE 02 — THE METHOD

FOUR STEPS.
NO VIBES.

Every compound here goes through the same four checks. The badger reads the actual studies, not the press releases.

READ THE STUDY
Every claim links back to a real source — a published trial, a regulator filing, or a preprint. No anonymous “studies show”; if we can't link it, we don't say it.
CHECK WHO IT WAS TESTED ON
Mice or people? 8 subjects or 2,000? Healthy volunteers or sick patients? The grade reflects who the compound actually worked on — not who it might work on.
TEST THE CLAIM AGAINST THE DATA
Vendor marketing copy gets checked line by line against the underlying studies. Overstatements get flagged. Sources are attached so you can verify.
GRADE IT
Each compound gets a letter grade (A through F) on three things: how strong the evidence is, how well its safety is understood, and how easy it is to get legally. A grade is not permanent — it moves whenever new trial data lands or a reader sends us a source we missed.
FILE 03 — THE GRADES

FIVE TIERS.
ONE SCALE.

A
GOLD STANDARD
FDA-approved, or large human trials with consistent results
B
PROMISING
Small human studies, or consistent animal evidence with plausible mechanism
C
SUGGESTIVE
Animal-only data, or a single small study — promising signal, not proof
D
WEAK / CLINIC ONLY
Old or contradictory studies, or clinic protocols without controlled trials
F
NO VERIFIABLE EVIDENCE
Unknown composition, unsupported claims, or marketing-only language
FILE 04 — THE LIBRARY

THE FILES.

A preview of the most-asked-about compounds. Each row shows our three grades and a one-line summary. Tap any row to read the full audit. Filter by grade with the buttons on the right.

Showing 8 of 63 files
Browse all 63 →
FILE 05 — THIS WEEK'S AUDIT
FILE 0042

THE BPC-157
RECEIPT.

BY THE BADGER 2 MIN READ UPDATED 18 APR 2026
BPC-157 has been called a “miracle peptide,” a “Wolverine drug,” and “the closest thing to actual regeneration.” It also might genuinely help heal tendons. Both can be true at the same time, and the gap between them is what this site is about.

BPC-157 is a short, 15-amino-acid peptide originally found in a protein in human stomach lining. In animal studies — and there are a lot of them — it consistently helps tendons, gut, and wounds heal faster. The biological story makes sense. The animals were almost all rats.

Where it gets thin is human data. As of April 2026, the public clinical-trial registry lists only two BPC-157 trials in humans: a 42-person safety study (no update since 2021) and an ongoing 120-person hamstring-injury trial. Neither has reported results yet.

That isn't damning — it's actually where most research peptides sit. Somewhere between “the rats love it” and “your insurance will cover it.” The honest framing is promising, but unproven in people — not safe and effective like aspirin.

What gets BPC-157 a B from us instead of a C: the animal evidence is unusually consistent across different labs, doses, and injury types. Independent replication is the strongest signal a research compound can have before human trials catch up.

BPC-157 isn't junk, and it isn't aspirin. The honest grade is promising — which is a useful word, if you let it mean what it actually means.
Sources
  1. [01] Phase 1 safety study (42 people, status unknown since 2021) — ClinicalTrials.gov NCT02637284
  2. [02] Phase 2 hamstring-strain trial (120 people, recruiting) — ClinicalTrials.gov NCT07437547
  3. [03] Added to the World Anti-Doping Agency's prohibited list in 2022 — Wikipedia summary
FILE 06 — THE QUESTIONS

YOU
ASKED.

No. We're a reference, not a prescription. Our job is to tell you how strong the evidence behind a compound actually is. What you do with that — including whether you talk to a doctor about it — is up to you.

Readers, eventually — through optional newsletter subscriptions. We don't take ad money from peptide vendors, supplement brands, or anyone whose product we might grade. No affiliate links anywhere on the site.

When the evidence does — not on a calendar. A grade moves when a trial reports, a regulator acts, or a reader brings us a source we missed. Every file shows the date it was last reviewed, so you can see for yourself how current it is.

Badgers don't care. They dig until they hit the thing. They aren't impressed by anyone's podcast. Same energy.

Send us the study. If a reader points us at a real source we missed or misread, we re-grade in public and note what changed. The grade history is part of every file.

An independent editorial project — not a clinic, not a medical journal, not a pharma company. We're not doctors or pharmacists. We summarize what published research says, link the sources, and let licensed clinicians handle the actual medical decisions. The whole site is open source — the code, the data, and the corrections trail all live on GitHub.

THE NEWSLETTER

RECEIPTS IN YOUR INBOX.

Sent only when there's something to send.

New audits, grade changes, and which trending compounds aren't worth your attention. No sponsors. No affiliate links. We never sell or share your email.

Free, always · unsubscribe anytime · we never sell or share your email